Archive | Healthcare Service & Pharmaceuticals RSS feed for this section

Mid Europa Plans LUX MED Group Sale by December 2012

17/09/2012

Comments Off

PE fund Mid Europa Partners have confirmed their intention to sell LUX MED, a leading Polish healthcare group that has a customer base of 1 million and runs 72 medical centres in the nation. The final sale agreement is expected to be signed off by the end of 2012. Bids are expected from top insurance [...]

Continue reading...

Turkish Healthcare Group Medical Park Could Sell, Go for IPO

13/09/2012

Comments Off

Bankers Credit Suisse and Goldman Sachs have been mandated by the Turkish group of hospitals, Medical Park, to look for sale offers or an initial public offering as an alternative. PE firm Carlyle Group has a 40 per cent stake in the company which it purchased in 2009; other shareholders include Dr Muharrem Usta and Haydar [...]

Continue reading...

Innova to Rejuvenate Polish Childbirth and Natal Care Segment with PLN 150 mln

12/09/2012

Comments Off

Leading Central European-focused PE fund Innova Capital has entered the Polish medical services sector in a big way, with an investment commitment of more than PLN 150 mln in Ujastek Gynaecological and Obstetrics Hospital. The fund will be utilized over the next two years in building a chain of healthcare centers focused on providing advanced medical [...]

Continue reading...

Penta Plans €3 Mln Injection Into Slovak Healthcare Centers

11/09/2012

Comments Off

After a Slovak Anti-monopoly Office decision came through, Penta Investments has confirmed a 100 per cent acquisition of Estate Consult, owner of the Svet zdravia group of regional hospitals. The EUR 3 mln investment, which is spread out through 2012, will result in the modernization and improvement of customer service capabilities of ten healthcare facilities [...]

Continue reading...

Penta Pops Pills, Acquires Pharma Units in Czech Republic from Celesio

27/08/2012

Comments Off

CEE-centric PE fund Penta Investments has entered an agreement with Celesio to purchase its Czech pharma retail chain Lloyds, as well as Gehe, its wholesale distribution company. The deal is worth EUR 84.5 mln and will culminate in the integration of the Lloyds stores into Ceska Lekarna, which runs the Czech pharmacy chain Dr. Max. [...]

Continue reading...

Primus Capital Injects €400 Mln Into Cancer Research Company HYD

24/08/2012

Comments Off

Primus Capital has made a EUR 400 mln investment commitment in cancer research and drug development company HYD. The investment will be rolled out in two phases and will allow the company to verify and validate the results of their Phase II human clinical trial for their patented deutériummegvonás, which is a new concept in tumor [...]

Continue reading...

Penta Investments May Lose Slovakian Private Insurance Company Dovera

15/08/2012

Comments Off

The Slovak government has arrived at a decision to eliminate private health insurance firms in the nation and bring all related services under a single system run by the state. However, the profitable private enterprises operating in this sector in Slovakia may show some resistance to the move. Prime Minister Robert Fico’s move to mandate [...]

Continue reading...

UFG-CapMan-EBRD Trio Take On 75% Stake In Russian Medical Lab Group KDL Test

28/06/2012

Comments Off

UFG Private Equity has led a successful investment bid along with CapMan Russiaand the European Bank for Reconstruction and Development, for medical diagnostics provider KDL Test. While UFG took the lion’s share at 40.3 percent, EBRD now holds 24 percent and CapMan takes away 10.7 percent from the deal. The remaining 25 percent stake in the [...]

Continue reading...

EBRD Strengthens Presence In Russia by Investing in Belaya Dacha

22/06/2012

Comments Off

Speaking of Russia, year 2012 seems to be the “Year of Health” at EBRD. Two of their investments targeted the area of healthcare, which is taken here in its broadest sense: as meaning medical services and products but also as a preventive, healthy lifestyle  initiative.   Earlier this year, in a transborder transaction, the EBRD [...]

Continue reading...

Arx Equity Expands Lexum Medica, Seeks Large Investment Opportunity In Polish Healthcare

29/05/2012

Comments Off

Arx Equity Partners, owners of Lexummedica, a networked group of ophthalmology clinics operating in Poland and the Czech Republic, having been unable to carry out their plan of a PE investment in the healthcare sector in 2011, now expect 2012 to see a major investment in this sector, likely in a single project such as [...]

Continue reading...

Portfolion Invests Heavily In Molecular Cancer Detection Technology Company KPS

21/05/2012

Comments Off

Portfolion has made a HUF 160 mln investment in KPS, a medical biotechnology company that specializes in detecting cancer through the use of molecular means. The investment will allow KPS to gain the lead position in this highly specialized field by expanding its marketing, sales and business development operations and make the technology available on [...]

Continue reading...

JEREMIE Winner DBH Allocates HUF 200 Mln to Hungarian Healthcare Company Indiso

18/05/2012

Comments Off

Hungarian VC fund company DBH, the investment partner of the JEREMIE Program since 2009, has made an investment of HUF 200 mln into healthcare service provider, Indiso. The Debrecen-based company provides medical services in the form of Speleotherapy, using natural salt (NaCl) to treat respiratory diseases caused by a variety of environmental and personal, social conditions [...]

Continue reading...

Carint Scanmed Majority Bought Out By American Heart Of Poland

02/05/2012

Comments Off

American Heart of Poland (AHP), the Polish network of cardiovascular treatment facilities across the South Krakow region, which is now owned by Advent International, has bought a majority stake (50 percent + 1) in Carint Scanmed, one of the country’s industry leaders. The purchase was made from the parent company, Scanmed Group which, in turn [...]

Continue reading...

German-Russian Biomedical Companies Hepatera And MYR Receive Monetary Booster

12/04/2012

Comments Off

In a joint funding venture by German and Russian entities, Hepatera, a Russian pharmaceutical start up that makes liver treatment and disease prevention drugs, as well as its partner, German company MYR, have received funding from top German VC firm High-Tech Gründerfonds, as well as Russian Venture Capital (via its Maxwell Biotech Venture Fund). The investment will [...]

Continue reading...

Rusnano and US venture firm tie up to improve Russian healthcare

19/03/2012

Comments Off

Rusnano has tied up with US healthcare specialist venture firm Domain Associates to co-invest up to USD 760 million to set up a medical device manufacturing and pharmaceutical facility in Russia, invest in US healthcare technology companies, and manage clinical trials of new drugs relevant for Russia. Rusnano is expected to commit USD 330 million while Domain’s [...]

Continue reading...

Quintiles and RVC Biofund join hands for Russian biopharma foray

12/03/2012

Comments Off

World’s leading bio-pharmaceuticals services company Quintiles and Russian Venture Company (RVC) Biofund have joined hands to set up a clinical development service company in Russia. The two firms have signed a definitive joint-venture agreement to expand healthcare development capabilities and to implement best international health practices in Russia. Quintiles (www.quintiles.com) Quintiles is a global pioneer [...]

Continue reading...

NanoDerm Receives $2.5 mln RVC Funding

22/02/2012

Comments Off

The Russian Venture Company PE seed fund has funded NanoDerm, the maker of nanocosmetic anti-aging products, with USD 2.5 mln (75 mln roubles). Zhespar-Bios, which is a co-investor in the round (25 mln roubles), is one of the co-developers of the double-encapsulation method which is used by NanoDerm. NanoDerm Profi ( nanoderm.ru) NanoDerm was founded in [...]

Continue reading...

MetLife acquires Aviva’s Hungarian business

09/02/2012

Comments Off

British insurance major Aviva has sold its life insurance and pensions business in Romania and life insurance business in Hungary and the Czech Republic to MetLife Inc. The businesses had combined assets of EUR 57 million at the end of H1, 2011. The deal is expected to be completed before the end of 2012, subject [...]

Continue reading...

Abraaj Capital Divests Interests In Acibadem Turkey

06/02/2012

Comments Off

UAE-based investment house Abraaj Capital  has divested its 50 percent stake in Turkish healthcare services provider, Acibadem. The divested shares are being transferred to Khazanah Nasional, the investment wing of the Malaysian government, as well as Integrated Healthcare Holdings. Acibadem, formerly owned fully by the Aydinlar family, will take its holdings down to 25 percent, with [...]

Continue reading...

Euroventures Takes Second Dose Of Hungarian Med Market

27/01/2012

Comments Off

After last year’s investment into Medimass, Euroventures once again takes the Hungarian pill and invests in the medical services sector in the country. For their first investment into Medimass,  Euroventures secured more than HUF 400 mln. MediMass develops intelligent surgical devices that will help cancer surgeons determine which tissue is cancerous and which is not. The equipment will [...]

Continue reading...